IVF (In Vitro Fertilisation) — Cost, Top Hospitals & Success Rates | MyMedicPlus

In vitro fertilisation (IVF) is a fertility treatment in which eggs are collected from a woman's ovaries and fertilised by sperm in a specialist embryology laboratory, outside the body. The fertilised egg — called an embryo — is then transferred back into the uterus, where it can implant and develop into a pregnancy. The term 'in vitro' comes from Latin meaning 'in glass', reflecting the laboratory dish in which fertilisation originally took place.

IVF was first successfully performed in the United Kingdom by Drs Patrick Steptoe and Robert Edwards, resulting in the birth of Louise Brown on 25 July 1978. Since then, more than 10 million people worldwide have been born through IVF, making it one of the most significant medical advances of the 20th century. Robert Edwards was awarded the Nobel Prize in Physiology or Medicine in 2010 for this work.

The IVF process takes approximately 4–6 weeks and involves a series of coordinated steps:

1. Ovarian stimulation: Daily hormone injections for 8–14 days stimulate the ovaries to produce multiple follicles (fluid-filled sacs, each containing an egg), rather than the single egg produced each natural cycle. This is monitored with regular ultrasound scans and blood tests.
2. Trigger injection: When the follicles reach the right size, a precisely timed injection triggers the eggs to mature. Egg collection occurs 35–36 hours later.
3. Egg collection: A short procedure under sedation in which a thin needle passes through the vaginal wall, guided by ultrasound, to aspirate the eggs from each follicle. It usually takes 15–30 minutes and most patients go home within a few hours.
4. Fertilisation: In the embryology laboratory, the collected eggs are mixed with sperm (from a partner or donor) — either by conventional insemination or by ICSI (injecting a single sperm directly into each egg).
5. Embryo culture: The fertilised eggs are grown in a controlled incubator for 3–6 days, developing from a single cell into a blastocyst of approximately 100–200 cells.
6. Embryo transfer: The best-quality embryo is placed gently into the uterus through a thin tube passed through the cervix — a procedure similar to a smear test and usually requiring no sedation. Surplus good-quality embryos are frozen for future use.
7. Pregnancy test: A blood test 14 days after transfer confirms whether the embryo has implanted and a pregnancy has begun.

IVF does not guarantee a pregnancy. Most cycles do not result in a live birth, and multiple cycles are often needed. However, for many people, it is the most effective fertility treatment available — and for some, it is the only path to biological parenthood.

IVF is the most versatile assisted reproductive technology. It can be used to overcome fertility problems in both partners, and it can be adapted for use with donor eggs, donor sperm, or a gestational surrogate. It benefits a wide range of individuals and couples:

Blocked or Damaged Fallopian Tubes

IVF bypasses the fallopian tubes entirely — eggs are collected directly from the ovaries and fertilisation occurs in the lab, so tubal function is irrelevant. IVF was originally developed for this indication and remains the definitive treatment for tubal factor infertility.

Male Infertility

When sperm count, motility, or normal morphology are significantly below normal, IVF with ICSI (intracytoplasmic sperm injection) can achieve fertilisation with very few sperm — sometimes only a handful extracted surgically from the testis. ICSI is now used in over 55% of IVF cycles in the UK.

Unexplained Infertility

When all standard fertility tests come back normal but conception has not occurred after a year or more of trying, IVF can often achieve a pregnancy where simpler treatments have not.

Endometriosis

Endometriosis — a condition where tissue similar to the uterine lining grows outside the uterus — affects fertility through distorted pelvic anatomy, altered tubal function, and impaired egg quality. IVF achieves good results even in moderate to severe endometriosis.

Ovulation Problems

For women who do not ovulate regularly (e.g. due to polycystic ovary syndrome, PCOS), IVF is highly effective once an appropriate stimulation protocol is used. Women with PCOS require careful monitoring during stimulation to minimise the risk of ovarian hyperstimulation syndrome (OHSS).

Fertility Preservation After Cancer

IVF can be used to collect and freeze eggs or embryos before chemotherapy or radiotherapy that may damage the ovaries. This process — called oncofertility — has allowed many cancer survivors to have biological children after treatment. NHS and most private clinics offer priority access for cancer patients requiring urgent fertility preservation.

Same-Sex Couples and Single Parents

IVF makes biological parenthood possible for female same-sex couples (using the eggs of one partner or both, and donor sperm) and for single women (using donor sperm). For male same-sex couples and single men, IVF combined with gestational surrogacy and donor eggs is the pathway to biological fatherhood.

Genetic Disease Prevention

Couples who carry genetic conditions (such as cystic fibrosis, Huntington's disease, sickle cell anaemia, or BRCA mutations) can use IVF combined with preimplantation genetic testing (PGT) to have embryos tested before transfer, selecting those unaffected by the condition.

Eligibility for IVF depends on a combination of clinical, age, and (for NHS funding) commissioning criteria. Here is what the assessment typically involves:

Female Age

Female age is the single strongest predictor of IVF success. NICE guideline NG156 recommends IVF for women up to and including the age of 42 where specific criteria are met. Above 43, the chance of success with own eggs becomes very low (<5% per transfer, HFEA 2022), and clinics will discuss whether donor egg IVF is more appropriate.

Fertility Tests You Will Need

• Ovarian reserve: A blood test for anti-Müllerian hormone (AMH) and an ultrasound scan to count antral follicles tells the clinic how many eggs your ovaries are likely to produce with stimulation.
• Fallopian tube assessment: An X-ray procedure (hysterosalpingography, or HSG) or ultrasound (HyCoSy) to check whether your tubes are open — although blocked tubes do not prevent IVF, the information helps guide treatment planning.
• Semen analysis: A standard analysis of the male partner's sperm count, movement, and shape is performed before starting treatment.
• Blood tests: Hormone levels (FSH, LH, oestradiol), infectious disease screening (HIV, hepatitis B and C, syphilis), and rubella immunity are checked.
• Uterine assessment: An ultrasound scan or saline sonogram to check the uterine cavity for polyps, fibroids, or scarring that could impair implantation.

NHS Eligibility Criteria (England)

NICE recommends that the NHS fund up to 3 full IVF cycles for women under 40 who have been trying to conceive for at least 2 years (or 12 IUI cycles). Women aged 40–42 may receive 1 NHS cycle if they meet other criteria. However, in reality, NHS funding varies dramatically: many Integrated Care Boards (formerly CCGs) fund only 1 cycle, some apply additional restrictions (BMI limits, non-smoking requirements, no previous live children from either partner), and some areas have paused IVF funding entirely. Checking your local ICB's policy is essential before relying on NHS funding.

Private IVF

If you do not meet NHS eligibility criteria, or if waiting times are prohibitive, private IVF is available without the age or cycle restrictions of the NHS, though funding is entirely personal.

An IVF cycle is a carefully timed sequence of medical steps, each building on the last. Here is what patients typically experience:

Before You Start: Baseline Scan and Medications

You attend the clinic on day 2 or 3 of your period for a baseline scan to confirm no ovarian cysts, and your protocol and medications are confirmed. Most patients use the GnRH antagonist (short) protocol — the most widely used today — in which stimulation injections begin from day 2–3 of your period.

Stimulation Phase (Days 2–12 Approximately)

You inject yourself daily with FSH (follicle-stimulating hormone) — a process that most patients learn quickly and manage confidently at home. Every 2–3 days you attend the clinic for a monitoring ultrasound scan to measure follicle size and number, and sometimes a blood test for oestradiol. The stimulation phase typically lasts 8–12 days.

When the lead follicles reach 17–18 mm diameter — indicating mature eggs inside — you give the trigger injection (hCG or GnRH agonist, depending on your protocol) at a precisely specified time. Egg collection is booked for 35–36 hours later.

Egg Collection Day

This is usually the most anxiety-provoking day of the cycle. You arrive fasting, receive intravenous sedation, and the procedure is performed by the fertility specialist in a procedure room adjacent to the embryology lab. The embryologist confirms how many eggs have been collected immediately after the procedure. You receive this number in recovery — the 'egg collection number' that patients often share anxiously. Common numbers are 5–12 eggs for a normal responder; fewer for poor responders; more for high responders (PCOS). You go home the same day, typically within 2–4 hours.

Fertilisation Report (Day 1)

The morning after egg collection, the clinic phones with your fertilisation report — how many eggs were mature and how many fertilised normally (two pronuclei visible). This is often the second anxious milestone. Typical fertilisation rates are 60–75% for conventional insemination and 70–85% for ICSI.

Embryo Updates (Days 3–6)

Most clinics update patients at Day 3 (to report on embryo development) and again at Day 5 or 6 (blastocyst report). Many patients experience a reduction in numbers from the fertilisation report to the final blastocyst number, which is normal — only the strongest embryos successfully complete development. A typical result might be: 10 eggs collected → 8 mature → 6 fertilised → 4 at Day 3 → 2 good-quality blastocysts at Day 5.

Embryo Transfer

One blastocyst (in most cases — see Single Embryo Transfer below) is warmed and transferred into the uterus using a thin catheter under ultrasound guidance. The procedure takes approximately 10 minutes and requires no sedation. You can return to normal activities the same day. Surplus good-quality blastocysts are frozen (vitrified) for future use.

The Two-Week Wait

The 14 days between transfer and the pregnancy blood test is widely recognised as the most emotionally demanding part of IVF. Progesterone pessaries (or injections) are continued throughout. There are no restrictions on gentle activity. Most clinics advise avoiding home urine pregnancy tests, which can give misleading results in the early days if residual trigger hCG is still in the system.

IVF success rates are most reliably quoted as live birth rate per embryo transfer — the percentage of transfer cycles that result in a baby born alive. This is more meaningful than 'pregnancy rate per cycle started,' which counts biochemical pregnancies (a positive test that does not result in a live birth) and does not account for cycles cancelled before egg collection.

HFEA UK Data (2022)

Based on all IVF cycles reported to the Human Fertilisation and Embryology Authority (HFEA) in 2022:

• Under 35: approximately 32% live birth rate per embryo transfer
• 35–37: approximately 25% live birth rate per embryo transfer
• 38–39: approximately 19% live birth rate per embryo transfer
• 40–42: approximately 11% live birth rate per embryo transfer
• Over 42 (own eggs): approximately 5% live birth rate per embryo transfer
• Donor eggs (any recipient age): approximately 28–38% live birth rate per transfer (driven by donor age, not recipient age)

These are averages across all UK licensed clinics. Individual clinic success rates can be looked up on the HFEA's online 'Find a Clinic' tool, which adjusts for patient age and diagnosis to allow fair comparison.

How Many Cycles Will I Need?

There is no fixed answer, as each cycle is independent. For a woman under 35, approximately 1 in 3 fresh transfers results in a live birth. However, cumulative success rates across multiple transfers (using both fresh and frozen embryos from one stimulation cycle) are considerably higher. Research published in the New England Journal of Medicine (Malizia et al., 2009) found that over 6 complete IVF cycles, approximately 65–86% of women under 35 achieved a live birth. For women over 40, cumulative rates over the same number of cycles were approximately 23–42% using own eggs.

The practical advice is not to judge IVF on the outcome of a single cycle, but to plan in terms of a course of treatment (multiple cycles and/or FET cycles) where resources and eligibility allow.

Cryopreservation: Maximising Value from Each Stimulation Cycle

Modern vitrification technology has transformed IVF by allowing surplus embryos to be stored with over 95% survival after thawing. This means that one stimulation cycle (one egg collection) can yield multiple frozen embryo transfers, each giving an independent chance of pregnancy. For some patients, the frozen embryo transfers from a single stimulation cycle ultimately produce multiple children — making the cost-per-child substantially lower than each transfer in isolation.

IVF is generally safe, but patients must be informed of both medical risks and the emotional and physical demands of treatment before starting.

Ovarian Hyperstimulation Syndrome (OHSS)

OHSS occurs when the ovaries over-respond to stimulation, producing too many follicles and causing fluid to leak from the blood vessels into the abdomen and chest. Mild bloating and discomfort occur in 20–30% of stimulated cycles and resolve without treatment. Moderate OHSS (nausea, vomiting, visible abdominal swelling) occurs in 3–6%. Severe OHSS — requiring hospital admission for IV fluids and monitoring — occurs in under 2% of cycles. Women with PCOS and those with high egg counts are at highest risk. If your clinic considers you high-risk, they may use a 'freeze-all' strategy — vitrifying all embryos and deferring transfer to a future month, which prevents OHSS from being worsened by early pregnancy hormones.

Multiple Pregnancy and Single Embryo Transfer

In the early years of IVF, transferring two or three embryos at once significantly increased the chance of twins or triplets. Today, the medical consensus — reflected in HFEA guidance and supported by the landmark Multiple Births Minimisation strategy — is that elective single embryo transfer (eSET) should be the norm wherever possible.

Twin pregnancies are 6 times more likely to be born prematurely than singletons, twice as likely to result in a low-birthweight baby, and carry a significantly higher risk of cerebral palsy, neonatal intensive care admission, and perinatal death. The NHS and most professional bodies now recommend transferring one embryo at a time as the safest approach for both mother and baby, even if it slightly reduces the chance of pregnancy in any one cycle.

The UK multiple birth rate from IVF fell from 24% in 2009 to under 6% by 2022 — a public health success attributable almost entirely to the adoption of eSET.

Miscarriage

IVF pregnancies carry a similar overall miscarriage rate to natural pregnancies when corrected for maternal age — approximately 15–25%. However, because IVF pregnancies are detected very early by blood test, more early losses are registered than in natural conception. Women over 40 have higher miscarriage rates due to the higher rate of chromosomal aneuploidy in older eggs. Preimplantation genetic testing for aneuploidies (PGT-A) reduces miscarriage risk by selecting chromosomally normal embryos for transfer.

Ectopic Pregnancy

The risk of ectopic pregnancy (implantation in the fallopian tube rather than the uterus) is approximately 2–5% in IVF cycles, higher than in natural conception, reflecting the underlying tubal factor diagnoses that many IVF patients carry. An early viability scan at 6–7 weeks gestation is therefore important to confirm intrauterine location of the gestational sac.

Long-Term Cancer Risk

Multiple large cohort studies and a Cochrane review have found no significant increase in breast, ovarian, or uterine cancer risk from IVF stimulation drugs when compared with infertile women who did not have IVF. Existing evidence is reassuring, though ongoing follow-up studies continue to monitor outcomes in the large populations of IVF-treated women.

The physical process of IVF is well described and manageable for most patients. The emotional journey is harder to prepare for — and is often the most challenging aspect of treatment.

The Emotional Landscape

IVF involves a series of high-stakes milestones — each with the potential for hope and disappointment. Egg collection numbers, fertilisation reports, blastocyst updates, and finally the pregnancy test result create a roller coaster of anticipation, anxiety, and — in failed cycles — grief. Research consistently shows that a failed IVF cycle produces grief responses comparable in psychological intensity to bereavement.

It is important for patients to know that emotional distress during IVF is normal and expected — not a sign of weakness or a reason to feel embarrassed. Both partners in a couple, and solo patients, experience intense emotions, often at different times and in different ways.

HFEA-Licensed Clinic Counselling Requirement

Under HFEA licensing conditions, all UK licensed fertility clinics are required to offer counselling from a qualified counsellor with fertility specialisation to all patients before, during, and after treatment. This includes implications counselling (exploring what IVF means for the individual), support counselling (managing the emotional experience of treatment), and therapeutic counselling (addressing longer-term distress after failure or loss).

Patients should accept this offer of counselling proactively — not only when in crisis. Research shows that patients who access counselling throughout treatment have better emotional outcomes and are more likely to make informed decisions about when to continue or stop treatment.

Relationship Strain and Support

IVF can place significant strain on relationships. Couples often cope differently, experience different timelines of hope and grief, and may disagree about how many cycles to attempt, how much to spend, or whether to consider donor eggs or adoption. Open communication, couples therapy where needed, and clear agreement in advance about decision points help protect the relationship through treatment.

Deciding When to Stop

Deciding when to stop IVF is one of the hardest decisions in fertility treatment. There is no universal answer — it depends on clinical prognosis, financial capacity, emotional reserves, and personal values. A good fertility clinic will proactively review your prognosis after failed cycles and provide honest, compassionate guidance on whether continuing is likely to be beneficial. Organisations such as Fertility Network UK and the HFEA provide independent resources for patients considering stopping treatment.

Life After Unsuccessful IVF

For people who do not achieve a pregnancy through IVF, grief, loss of identity, and a need to rebuild life goals are all common. Fertility counsellors, peer support groups (Fertility Network UK, RESOLVE in the USA), and community resources can provide significant support through this process. Many people find that donor egg IVF, embryo donation, adoption, or child-free living — after appropriate time and processing — offer fulfilling pathways forward.

IVF costs are a significant practical concern for most patients. Understanding the cost components, funding options, and international alternatives is important for financial planning.

NHS Funding (England): What NICE Recommends vs What Is Delivered

NICE guideline NG156 recommends the NHS fund up to 3 full IVF cycles for eligible women under 40 in England. A 'full cycle' includes one egg collection plus all associated fresh and frozen embryo transfers from that stimulation. However, the gap between what NICE recommends and what is actually funded is significant:

• Many Integrated Care Boards (ICBs) fund only 1 NHS IVF cycle
• Some ICBs restrict funding to women under 37 or 38
• Some ICBs have removed IVF from funded services entirely
• BMI restrictions (typically 19–30), smoking restrictions, and the 'no existing children' rule (no previous live birth for either partner in some areas) are common additional eligibility barriers

Scotland, Wales, and Northern Ireland have different — often more generous — NHS IVF policies than England.

Private IVF Costs (United Kingdom)

• Standard IVF cycle (including monitoring, anaesthetic, egg retrieval, fertilisation, embryo culture, one fresh transfer): £5,000–£8,000
• IVF medications (FSH, antagonist, trigger, progesterone): £1,000–£2,500 per stimulation cycle
• ICSI add-on: £800–£1,500 additional
• Frozen embryo transfer (FET): £1,500–£3,000 plus medication (£200–£500)
• PGT-A (preimplantation genetic testing): £2,500–£4,500 additional
• Embryo storage: £300–£600 per year

International Costs (2025–2026)

• Spain: €3,500–€6,000 per cycle — popular for egg donation (generous regulations, high-quality clinics)
• Czech Republic: €2,500–€4,500 per cycle — major European medical tourism destination for IVF
• Greece: €3,000–€5,000 per cycle — growing reputation for donor egg IVF
• India (NABH-accredited): ₹80,000–₹1,50,000 (approximately $1,000–$1,800) per cycle
• USA: $15,000–$25,000 per cycle — high quality but very expensive without insurance; some states (Illinois, New York, New Jersey) now mandate IVF insurance coverage

Multi-Cycle Packages and Refund Schemes

Many UK private clinics offer discounted multi-cycle packages (e.g. 2 or 3 cycles at a reduced combined price) or 'money-back' / refund schemes in which a higher upfront fee buys multiple transfers with a partial refund if no live birth results. These schemes vary widely in their terms — always check eligibility age limits, exclusions, what constitutes a 'live birth,' and the financial stability of the clinic offering the scheme before committing.

IVF is not the only fertility treatment, and for some patients, a simpler or different approach may be more appropriate. Alternatives include:

IUI (Intrauterine Insemination)

For couples with unexplained infertility, mild male factor infertility, or donor sperm use, intrauterine insemination (IUI) is a simpler, less expensive, and less invasive first step before IVF. NICE NG156 recommends stimulated IUI may be offered for unexplained infertility before IVF in women under 37. Per-cycle success rates are lower than IVF (8–15%), but cumulative success over 3–6 cycles reaches 30–40% for appropriate patients, at approximately 10–20% of the cost of IVF.

Ovulation Induction with Timed Intercourse

For women with irregular cycles or anovulation (PCOS, hypothalamic amenorrhoea), stimulating ovulation with clomifene (or letrozole, which evidence now favours for PCOS) and timing intercourse can achieve pregnancy without any laboratory procedures. This is the first-line treatment for anovulatory infertility with patent tubes and normal sperm.

Donor Egg IVF

For women over 43–45, or with very poor ovarian reserve at any age, IVF using eggs donated by a young screened donor achieves live birth rates of 28–40% per transfer regardless of the recipient's age, making it substantially more effective than own-egg IVF in this group. The child has the intended mother's partner's sperm (or donor sperm) and the donor's egg genetics, but is gestated and birthed by the intended mother — whom the law recognises as the birth mother.

Embryo Donation

Couples who cannot use their own eggs or sperm may receive embryos donated by other IVF patients who have completed their families and have surplus embryos in storage. Embryo donation (sometimes called 'embryo adoption') is the least expensive form of third-party reproduction and is regulated in the UK by the HFEA. The child will have no genetic connection to either intended parent.

Adoption and Foster Care

Adoption and foster care provide a route to parenthood for a child who needs a family, without fertility treatment. Domestic adoption and fostering are regulated separately from fertility treatment and involve their own eligibility assessments, home studies, and matching processes.

Fertility Preservation (Egg or Embryo Freezing)

For individuals who are not ready to conceive now but wish to keep options open — whether due to cancer treatment, relationship timing, or personal circumstances — egg freezing (oocyte cryopreservation) or embryo freezing through IVF provides a means of preserving fertility. Success rates from frozen eggs are highest when freezing occurs before age 35, and decline significantly above 37–38. Eggs may be stored for up to 10 years (extendable in medical circumstances) under HFEA regulations.